Oncotarget · 2013 · 19 citations · 17 references
MedicineCell BiologyOncologyMolecular OncologyNeoplasiaOncogenesMalignant NeoplasmsOncogenic Signaling PathwaysPancreatic CancerRas Family OncogenesReceptor Tyrosine Kinase OncogenesCaveolin-mediated EndocytosisEarly Endosome MaturationEliminationExtracellular Signal-regulated Kinase SignalingMutationOncogenic Ras MutationsOncogenic Ras SignalingP53 Mutation
// Sun-Hye Lee 1 , Tae-Gyun Woo 1 , Su-Jin Lee 1 , Jin-Sik Kim 2 , Nam-Chul Ha 2 , Bum-Joon Park 1 1 Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, Korea (Republic of) 2 Department of pharmaco-engineering, College of Pharmacy, Pusan National University, Busan, Korea (Republic of) Correspondence: Bum-Joon Park, email: // Keywords : p53 core domain; Oncogenic K-Ras; Caveolin-1; Drug delivery Received : October 29, 2013 Accepted : December 1, 2013 Published : December 2, 2013 Abstract K-Ras mutation is detected in over 30% of human malignancies. In particular, 90% of human pancreatic cancers are initiated by K-Ras mutation. Thus, selective elimination of K-Ras mutated cells would be a plausible strategy to prevent or cure the malignancies. In our previous reports, it has been revealed that oncogenic K-Ras promotes the exocytosis of p53 with Snail. In this study, we have followed the final destination of extracellular p53, which is secreted by the Snail complex. Here we provide evidences that p53, exported from K-Ras-mutated cells, is specifically re-endocytosed by oncogenic K-Ras-containing cancer cells. The p53 DNA-binding domain directly associates with caveolin-1 and enters K-Ras mutated cells through early endosome-mediated endocytosis. Using a serial deletion approach, we revealed that a fragment of human p53 extending from 93-143 amino acids (AA) is responsible for binding with caveolin-1 and for endocytosis. In contrast, p53-Snail binding occurs at the 143-193 aa region. Finally, through in vivo study, we confirmed that injected recombinant p53 could be up-taken by tumor tissues, constructed by oncogenic K-Ras transformed MEF cells. In contrast, the tumors formed by H-Ras mutated MEF cells did not accumulate the injected p53 protein. These results indicate that the p53 fragment might be useful as a specific delivery tool into K- Ras mutated cells as well as a diagnostic method.
17
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones, D. Williams Parsons, Jimmy Lin et al. · Science · 2008 · 4K citations · Full text
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding, Gad Getz, David A. Wheeler et al. · Nature · 2008 · 2.7K citations · Full text
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Eric Macia, Marcelo Ehrlich, Ramiro Massol et al. · Developmental Cell · 2006 · 2K citations · Full text
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Leisa Johnson, Kim L. Mercer, Doron C. Greenbaum et al. · Nature · 2001 · 1.2K citations
p53 Antibodies in the sera of patients with various types of cancer: a review.
Thierry Soussi · PubMed · 2000 · 556 citations
Life Sciences, Immunology, Oncology +15